Results 151 to 160 of about 46,918 (224)

Neuroprotection in Diabetes Retinal Disease: An Unmet Medical Need. [PDF]

Int J Mol Sci
Ramos H, Simó-Servat O.
europepmc   +1 more source

Glutamate Receptor Agonists as Triggers of Neurotoxicity: Decoding Pathways of Five Neurotoxins and Potential Therapeutic Targets. [PDF]

ACS Omega
Turcatel GA, Moura S.
europepmc   +1 more source

Crocin Mitigates Glutamate Excitotoxicity and Tau Hyperphosphorylation by Modulating EAAT2 and Akt/Tau Pathway in a Scopolamine-induced Rat Model of Alzheimer's Disease. [PDF]

Neurochem Res
El-Baga SE, Hassan MH, Awadalla EA, Abd El-Kader AEM.   +3 more
europepmc   +1 more source

Why acetylcholinesterase inhibitors should be considered disease-modifying drugs for Alzheimer's disease? [PDF]

Aging Clin Exp Res
Zuliani G, Cervellati C, Zuin M, Brombo G.   +3 more
europepmc   +1 more source

Breaking the cycle of excitotoxicity: blood glutamate scavenging provides robust neuroprotection in spinal cord injury. [PDF]

Inflamm Regen
Levin J, Goldshmit Y, Lavender R, Yakovchuk A, Banyas E, Baltovska R, Benbenishty A, Ruban A.   +7 more
europepmc   +1 more source

Guanosine contributes to rapid purinergic regulation of dopamine during ischemia. [PDF]

Purinergic Signal
Weese-Myers ME, Hassan ASA, Ross AE.
europepmc   +1 more source

Effect of riluzole on cognitive and functional outcomes after severe traumatic brain injury: a randomized controlled trial. [PDF]

BMC Neurol
Shojaei SH, Karimi M, Kavakebian M, Amini N, Derakhshi A.   +4 more
europepmc   +1 more source